Crescita Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRRTF research report →
Price Chart
About the company
Crescita Therapeutics Inc. , a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services.
- CEO
- Serge Verreault
- IPO
- 2016
- Employees
- 65
- HQ
- Laval, QC, CA
Get TickerSpark's AI analysis on CRRTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $10.40M
- P/E
- -43.17
- PEG
- -1.78
- P/S
- 0.63
- P/B
- 1.02
- EV/EBITDA
- 5.32
- Div Yield
- 0.00%
- Gross Margin
- 52.39%
- Op Margin
- -5.02%
- Net Margin
- -1.38%
- ROE
- -2.07%
- ROIC
- -6.87%
Latest fiscal year · YoY change
- Revenue
- $21.10M+7.8%
- Gross Profit
- $10.36M+7.9%
- Op Income
- $-1,021,166
- Net Income
- $-91,924+96.7%
- EPS
- $-0.00+96.5%
- OCF Growth
- -60.7%
- FCF Growth
- -52.0%
- 52W High
- $0.57
- 52W Low
- $0.02
- 50D MA
- $0.55
- 200D MA
- $0.38
- Beta
- -0.12
- RSI (14)
- 58
- Avg Volume
- 2.20K
No earnings-call transcripts are available for CRRTF yet.
- Free Float
- 76.1%
- Shares Outstanding
- 18.61M
- Float Shares
- 14.17M
Our CRRTF coverage
Recent articles, reports, and earnings notes.
No research on CRRTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRRTF report →Knight Announces Early Warning Filing Regarding Shares of Crescita
globenewswire.com · Jun 5
Crescita Therapeutics Inc. Announces Closing of Arrangement
businesswire.com · Jun 3
Crescita Therapeutics Inc. Announces Final Consideration Payable to Shareholders Pursuant to Arrangement with ClinActiv
businesswire.com · Jun 1
Crescita Therapeutics Inc. Obtains Final Order Approving Plan of Arrangement
businesswire.com · May 20
Crescita Obtains Shareholder Approval To Be Acquired By ClinActiv Holdings
businesswire.com · May 14
Crescita Reports First Quarter 2026 Results
businesswire.com · May 11
Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings
businesswire.com · Apr 22
Crescita Reports Q4 and Fiscal 2025 Results
businesswire.com · Mar 31
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.